Evolent Health (EVH) Income towards Parent Company (2014 - 2026)

Evolent Health has reported Income towards Parent Company for 13 years, with the latest figure at -$28.4 million in Q2 2026.

• On a quarterly basis, Income towards Parent Company fell 42.55% year-over-year to -$28.4 million in Q2 2026; TTM through Jun 2026 was -$504.9 million, a 286.95% decrease from a year earlier, with the FY2025 full-year figure at -$534.5 million, down 767.39% from the prior year.
• Income towards Parent Company was -$28.4 million for Q2 2026 at Evolent Health, down from -$26.6 million in the prior quarter.
• The five-year high for Income towards Parent Company was $2.1 million in Q3 2022, with the low at -$429.1 million in Q4 2025.
• Average Income towards Parent Company over 5 years is -$43.5 million, with a median of -$21.8 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: Income towards Parent Company surged 116.28% in 2022, then sank 1781.11% in 2025.
• Over 5 years, Income towards Parent Company stood at -$11.3 million in 2022, then sank by 194.66% to -$33.4 million in 2023, then surged by 31.66% to -$22.8 million in 2024, then tumbled by 1781.11% to -$429.1 million in 2025, then soared by 93.39% to -$28.4 million in 2026.
• The last three Income towards Parent Company figures came in at -$28.4 million (Q2 2026), -$26.6 million (Q1 2026), and -$429.1 million (Q4 2025), per Business Quant data.